%20Logo%20Transparent%20alt.png)
Mindsigns Health™ - a global neuropsychiatry platform with AI-powered automated EEG interpretation and remote monitoring software for serious mental illness - is pleased to announce the appointment of Dr. Manu Sidhu as Chief Medical Officer, Mental Health.
Dr. Sidhu has been an integral contributor to Mindsigns Health™ for several years in an advisory capacity. In this new role, he will take on a more active leadership position, guiding the company’s mental health strategy, advancing product development, and driving innovative approaches to improve care delivery.
“Dr Sidhu has worked in mental health services across the UK and Australia and brings experience not only in bridging healthcare, entrepreneurship and technology but also a dedication to addressing the unmet needs driving the growing global mental health crisis. Manu will continue to enhance our solutions for monitoring and addressing serious mental health conditions. His focus will include refining the clinical positioning and effectiveness of Mindsigns’ product, GenMind™, while supporting our international growth and broader patient impact”
Michel Birnbaum
CEO
Mindsigns Health™
“Since 2022, working with Mindsigns Health™ has led to some of the most fulfilling work of my career. By giving greater insight into the mental state of each patient, GenMind™ helps clinicians better understand the signs and symptoms of mental illness so they can make more informed care decisions. As Chief Medical Officer of our Mental Health offering, I’m honored to take on more responsibility in shaping our mental health strategy and improve standards of care for people with serious mental illness - one of healthcare’s most neglected patient groups.”
Dr Manu Sidhu
Chief Medical Officer, Mental Health
Mindsigns Health™
About Mindsigns Health™ Inc.:
Mindsigns Health™ develops a suite of cloud-based tools for neuropsychiatric illnesses that process various types of information to infer insights, help with treatment monitoring, symptom evolution and eventually better outcomes through more timely interventions. The product platform drives towards improving the patient journey and empowering the doctor-patient relationship from automated interpretation and analysis of EEG signals in clinical and ambulatory environments to the use of audio digital biomarkers to enable the remote monitoring of negative symptoms and cognitive impairment in serious mental health disorders.
Mindsigns Health™ has a strong track record of delivering clinical validation projects. Mindsigns Health™ has fulfilled the AI Quality Assessment Framework and has obtained the ISO 13485-2016 certification demonstrating the maturity of their process and drive to deliver quality products and impact in healthcare.
If you have any questions or require additional information about our upcoming product and services, please contact Mindsigns Health™ Inc. at www.mindsignshealth.com or contact michel.b@mindsignshealth.com.
Mindsigns Health™
Contact: Michel Birnbaum CEO
Comentários